Use of triple and quadruple neurohormonal blockade in heart failure: new data from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM)-Added trial

Weir, R., McMurray, J. , Granger, C., Puu, M., Ostergren, J., Yusuf, S., Swedberg, K. and Pfeffer, M. (2006) Use of triple and quadruple neurohormonal blockade in heart failure: new data from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM)-Added trial. European Heart Journal, 27(Suppl.),

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:McMurray, Professor John
Authors: Weir, R., McMurray, J., Granger, C., Puu, M., Ostergren, J., Yusuf, S., Swedberg, K., and Pfeffer, M.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
College of Medical Veterinary and Life Sciences
Journal Name:European Heart Journal

University Staff: Request a correction | Enlighten Editors: Update this record